Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime®
✍ Scribed by E.M. Netto; P.D. Marsden; E.A. Llanos-Cuentas; J.M.L. Costa; C.C. Cuba; A.C. Barreto; R. Badaró; W.D. Johnson; T.C. Jones
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 409 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986
## Abstract The medical records of 493 patients with restless legs syndrome (RLS) from three major centers were studied to determine the number and outcome of patients who had been treated with opioids as a monotherapy. At one time or another 113 patients (51 men, 62 women; age range, 37–88 years)
## Abstract We followed the course in 100 consecutive patients with cervical dystonia (CD) after they were initially treated with botulinum toxin (BTX) in the form of Dysport 10 to 12 years ago. A total of 4 patients had died, and 6 were lost to follow‐up. Of the remaining 90 patients, 57 (63%) wer
We studied the long-term outcomes of 43 patients with chronic hepatitis C treated with one or two interferon cycles, in relation to hepatitis C virus RNA in serum and peripheral-blood mononuclear cells. After the first interferon cycle, 15 (35%) patients had normal transaminase levels, although only